Editorial: Bringing function to the forefront of cell therapy: how do we demonstrate potency?

Alasdair R. Fraser; Stuart M. Curbishley; Andy Roemhild; Kwong Tsang

PMC · DOI:10.3389/fimmu.2024.1472727·August 12, 2024

Editorial: Bringing function to the forefront of cell therapy: how do we demonstrate potency?

Alasdair R. Fraser, Stuart M. Curbishley, Andy Roemhild, Kwong Tsang

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Genes4

IFNG TNF TRBV20OR9-2 CXADRP1

Proteins4

Species1

Homo sapiens(human · species)

Chemicals3

PS dexamethasone ATMP

Diseases6

severe COVID COVID inflammatory damage EBV Tumour cytotoxicity

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsCAR-T cell therapy research